Press Releases
Teva Drives Positive Impact in Response to COVID-19 Pandemic
Recognizing our essential role in responding to the COVID-19 pandemic, we are doing all we can to ensure a sustainable supply of medicines and address the needs of patients and communities around the world.
During these uncertain times, Teva’s commitment...
IT & Data Management
Aptar and Sonmol Partner to Develop Digital Platform for Respiratory-Related Therapies
AptarGroup, Inc. a global leader in consumer dispensing, active packaging and drug delivery solutions and services, and Sonmol, a leading Chinese digital respiratory therapeutics company, have announced a collaboration for developing a digital therapies and services platform targeting respiratory...
Drug Research
CytoSMART to donate 100 live-cell imaging systems to assist COVID-19 researchers
CytoSMART Technologies is to donate 100 mini live-cell imaging systems to researchers in high containment labs worldwide. Labs working to combat COVID-19 will benefit from this initiative, as CytoSMART aims to reduce the huge workload currently facing researchers on projects vital to...
Press Releases
CPhI & P-MEC China moves to December date to enable international attendance
CPhI & P-MEC China 2020, the landmark 20th anniversary edition of China’s largest pharma exhibition, will now take place on 16-18 December 2020 at SNIEC in Shanghai .
The organizers secured the new date at the request of exhibitors to...
Press Releases
MedTest Dx Manufactures the Only FDA Approved Quantitative Test for G6PD, Critical when Considering COVID-19 Treatment
MedTest Dx, Inc., an established solution provider for clinical diagnostic testing, is providing a critical tool in the fight against COVID-19 with its Pointe Scientific-branded assay for the highly sensitive quantification of G6PD in whole blood. Understanding the G6PD...
Press Releases
Eagle Pharma Announces Laboratory Test Results Demonstrating In Vitro Antiviral Activity of RYANODEX Against Coronavirus SARS-CoV-2
Eagle Pharmaceuticals, Inc , a New Jersey-based pharmaceutical company announced that its product RYANODEX for injectable suspension inhibited the growth of SARS-CoV-2, the virus causing the COVID-19 pandemic, in a controlled in vitro laboratory test. On Tuesday, April 14,...
Press Releases
Soligenix Announces Exclusive Licensing Agreement for Novel Vaccine Adjuvant from BTG Specialty Pharmaceuticals
Soligenix, Inc , a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced that it has executed an agreement for the exclusive worldwide license of CoVaccine HT...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.